HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Soll Selected Research

3- (2,4- diamino- 6- (3- hydroxyphenyl)pteridin- 7- yl)phenol

3/2009Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
12/2006Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard Soll Research Topics

Disease

3Edema (Dropsy)
03/2008 - 03/2004
2Macular Degeneration (Age-Related Maculopathy)
01/2009 - 03/2008
2Neoplasms (Cancer)
01/2009 - 02/2007
2Choroidal Neovascularization
07/2008 - 03/2008
2Papilledema
07/2008 - 06/2008
2Myocardial Infarction
12/2006 - 03/2004
2Ischemia
12/2006 - 03/2004
1Fibrosis (Cirrhosis)
01/2019
1Chronic Obstructive Pulmonary Disease (COPD)
03/2009
1Asthma (Bronchial Asthma)
03/2009
1Pneumonia (Pneumonitis)
03/2009
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
03/2009
1Respiratory Tract Diseases (Respiratory Tract Disease)
03/2009
1Retinal Vein Occlusion
07/2008
1Weight Loss (Weight Reduction)
07/2008
1Vascular Diseases (Vascular Disease)
06/2008
1Eye Diseases (Eye Disease)
06/2008
1Philadelphia Chromosome
01/2008
1Inflammation (Inflammations)
12/2006
1Myocardial Ischemia (Ischemic Heart Diseases)
12/2006
1Infarction (Infarctions)
12/2006
1Reperfusion Injury
12/2006

Drug/Important Bio-Agent (IBA)

4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2008 - 03/2004
34- chloro- 3- (5- methyl- 3- ((4- (2- pyrrolidin- 1- ylethoxy)phenyl)amino)- 1,2,4- benzotriazin- 7- yl)phenolIBA
01/2009 - 03/2008
2Phosphotransferases (Kinase)IBA
01/2019 - 07/2008
2Protein Isoforms (Isoforms)IBA
03/2009 - 12/2006
2Phosphatidylinositols (Phosphatidylinositol)IBA
03/2009 - 12/2006
23- (2,4- diamino- 6- (3- hydroxyphenyl)pteridin- 7- yl)phenolIBA
03/2009 - 12/2006
2Retinaldehyde (Retinal)IBA
07/2008 - 06/2008
2src-Family KinasesIBA
06/2008 - 02/2007
1Discoidin Domain Receptor 1IBA
01/2019
1SmokeIBA
03/2009
1Interleukin-13IBA
03/2009
1SteroidsIBA
03/2009
1Phenol (Carbolic Acid)FDA Link
03/2009
1LipopolysaccharidesIBA
03/2009
1Biological ProductsIBA
03/2009
1MucinsIBA
03/2009
1Tirapazamine (SR 4233)IBA
01/2009
1Fluorescein (Funduscein)FDA LinkGeneric
07/2008
1ProdrugsIBA
03/2008
1Benzoates (Benzoate)IBA
03/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2008
1AminesIBA
02/2007
1Platelet Activating FactorIBA
12/2006
1Cadherins (E-Cadherin)IBA
03/2004

Therapy/Procedure

2Therapeutics
03/2009 - 06/2008
2Lasers (Laser)
07/2008 - 03/2008
1Topical Administration
07/2008
1Intraocular Injections
06/2008